Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Using buprenorphine to treat patients with opioid use disorder
Joshua K Radi1, Kieran J Fogarty, Mary D Lagerwey
1Joshua K. Radi is a physician assistant in the Hawaii Army National Guard's Weapons of Mass Destruction-Civil Support Team in Kapolei, Hawaii, and in the Department of Orthopedic Surgery at Tripler Army Medical Center. He also is a clinical educator in the University of Hawaii's Department of Surgery in Honolulu. Kieran J. Fogarty is director of the Interdisciplinary Health Sciences doctoral program at Western Michigan University in Kalamazoo, Mich. Mary D. Lagerwey is director of Western Michigan University's Bronson School of Nursing. The authors have disclosed no potential conflicts of interest, financial or otherwise. The views/opinions expressed are those of the authors and do not necessarily represent the views of the Department of the Army and/or the Department of Defense.
Abstract:
The US opioid epidemic is a complex problem that has resulted in legislative actions to make treatment more accessible to patients. Physician assistants (PAs) have taken an active role in expanding their scope of practice to keep up with treatment needs. This article describes opioid use disorder in the United States, treatment gaps, safe treatment with buprenorphine, and PA prescriptive authority.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
04:33Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
In Vivo MRI Analysis of Cranial Nerve Morphology in a Patient with Inner Ear Disorder
10:393D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Opioid Analgesics: Morphine and Other Natural Cogeners
